202 related articles for article (PubMed ID: 33805778)
41. Unique physicochemical profile of beta-amyloid peptide variant Abeta1-40E22G protofibrils: conceivable neuropathogen in arctic mutant carriers.
Päiviö A; Jarvet J; Gräslund A; Lannfelt L; Westlind-Danielsson A
J Mol Biol; 2004 May; 339(1):145-59. PubMed ID: 15123427
[TBL] [Abstract][Full Text] [Related]
42. Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains.
van Horssen J; Otte-Höller I; David G; Maat-Schieman ML; van den Heuvel LP; Wesseling P; de Waal RM; Verbeek MM
Acta Neuropathol; 2001 Dec; 102(6):604-14. PubMed ID: 11761721
[TBL] [Abstract][Full Text] [Related]
43. Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease.
Chatterjee P; Pedrini S; Stoops E; Goozee K; Villemagne VL; Asih PR; Verberk IMW; Dave P; Taddei K; Sohrabi HR; Zetterberg H; Blennow K; Teunissen CE; Vanderstichele HM; Martins RN
Transl Psychiatry; 2021 Jan; 11(1):27. PubMed ID: 33431793
[TBL] [Abstract][Full Text] [Related]
44. Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden.
Rembach A; Watt AD; Wilson WJ; Villemagne VL; Burnham SC; Ellis KA; Maruff P; Ames D; Rowe CC; Macaulay SL; Bush AI; Martins RN; Masters CL; Doecke JD;
J Alzheimers Dis; 2014; 40(1):95-104. PubMed ID: 24334723
[TBL] [Abstract][Full Text] [Related]
45. Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation.
Dermaut B; Kumar-Singh S; De Jonghe C; Cruts M; Löfgren A; Lübke U; Cras P; Dom R; De Deyn PP; Martin JJ; Van Broeckhoven C
Brain; 2001 Dec; 124(Pt 12):2383-92. PubMed ID: 11701593
[TBL] [Abstract][Full Text] [Related]
46. TGFβ pathway deregulation and abnormal phospho-SMAD2/3 staining in hereditary cerebral hemorrhage with amyloidosis-Dutch type.
Grand Moursel L; Munting LP; van der Graaf LM; van Duinen SG; Goumans MTH; Ueberham U; Natté R; van Buchem MA; van Roon-Mom WMC; van der Weerd L
Brain Pathol; 2018 Jul; 28(4):495-506. PubMed ID: 28557134
[TBL] [Abstract][Full Text] [Related]
47. A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
Gkanatsiou E; Portelius E; Toomey CE; Blennow K; Zetterberg H; Lashley T; Brinkmalm G
Neurosci Lett; 2019 May; 701():125-131. PubMed ID: 30807796
[TBL] [Abstract][Full Text] [Related]
48. Cross-talk between Aβ and endothelial SSAO/VAP-1 accelerates vascular damage and Aβ aggregation related to CAA-AD.
Solé M; Miñano-Molina AJ; Unzeta M
Neurobiol Aging; 2015 Feb; 36(2):762-75. PubMed ID: 25457560
[TBL] [Abstract][Full Text] [Related]
49. Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Abeta to physiologically relevant proteolytic degradation.
Tsubuki S; Takaki Y; Saido TC
Lancet; 2003 Jun; 361(9373):1957-8. PubMed ID: 12801742
[TBL] [Abstract][Full Text] [Related]
50. The Arctic amyloid-β precursor protein (AβPP) mutation results in distinct plaques and accumulation of N- and C-truncated Aβ.
Philipson O; Lord A; Lalowski M; Soliymani R; Baumann M; Thyberg J; Bogdanovic N; Olofsson T; Tjernberg LO; Ingelsson M; Lannfelt L; Kalimo H; Nilsson LN
Neurobiol Aging; 2012 May; 33(5):1010.e1-13. PubMed ID: 22118948
[TBL] [Abstract][Full Text] [Related]
51. High performance plasma amyloid-β biomarkers for Alzheimer's disease.
Nakamura A; Kaneko N; Villemagne VL; Kato T; Doecke J; Doré V; Fowler C; Li QX; Martins R; Rowe C; Tomita T; Matsuzaki K; Ishii K; Ishii K; Arahata Y; Iwamoto S; Ito K; Tanaka K; Masters CL; Yanagisawa K
Nature; 2018 Feb; 554(7691):249-254. PubMed ID: 29420472
[TBL] [Abstract][Full Text] [Related]
52. Reducing cerebral microvascular amyloid-beta protein deposition diminishes regional neuroinflammation in vasculotropic mutant amyloid precursor protein transgenic mice.
Miao J; Vitek MP; Xu F; Previti ML; Davis J; Van Nostrand WE
J Neurosci; 2005 Jul; 25(27):6271-7. PubMed ID: 16000616
[TBL] [Abstract][Full Text] [Related]
53. Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease.
Rembach A; Faux NG; Watt AD; Pertile KK; Rumble RL; Trounson BO; Fowler CJ; Roberts BR; Perez KA; Li QX; Laws SM; Taddei K; Rainey-Smith S; Robertson JS; Vandijck M; Vanderstichele H; Barnham KJ; Ellis KA; Szoeke C; Macaulay L; Rowe CC; Villemagne VL; Ames D; Martins RN; Bush AI; Masters CL;
Alzheimers Dement; 2014 Jan; 10(1):53-61. PubMed ID: 23491263
[TBL] [Abstract][Full Text] [Related]
54. Plasma Amyloid-β Levels, Cerebral Small Vessel Disease, and Cognition: The Rotterdam Study.
Hilal S; Akoudad S; van Duijn CM; Niessen WJ; Verbeek MM; Vanderstichele H; Stoops E; Ikram MA; Vernooij MW
J Alzheimers Dis; 2017; 60(3):977-987. PubMed ID: 28984600
[TBL] [Abstract][Full Text] [Related]
55. Antisense Oligonucleotide-Induced Amyloid Precursor Protein Splicing Modulation as a Therapeutic Approach for Dutch-Type Cerebral Amyloid Angiopathy.
Daoutsali E; Hailu TT; Buijsen RAM; Pepers BA; van der Graaf LM; Verbeek MM; Curtis D; de Vlaam T; van Roon-Mom WMC
Nucleic Acid Ther; 2021 Oct; 31(5):351-363. PubMed ID: 34061681
[TBL] [Abstract][Full Text] [Related]
56. Microstructural white matter integrity in relation to vascular reactivity in Dutch-type hereditary cerebral amyloid angiopathy.
Schipper MR; Vlegels N; van Harten TW; Rasing I; Koemans EA; Voigt S; Luca A; Kaushik K; van Etten ES; van Zwet EW; Terwindt GM; Biessels GJ; van Osch MJ; van Walderveen MA; Wermer MJ
J Cereb Blood Flow Metab; 2023 Dec; 43(12):2144-2155. PubMed ID: 37708241
[TBL] [Abstract][Full Text] [Related]
57. Extracellular matrix modulator lysyl oxidase colocalizes with amyloid-beta pathology in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis--Dutch type.
Wilhelmus MM; Bol JG; van Duinen SG; Drukarch B
Exp Gerontol; 2013 Feb; 48(2):109-14. PubMed ID: 23267843
[TBL] [Abstract][Full Text] [Related]
58. The effects of AbetaPP mutations and APOE polymorphisms on cerebral amyloid angiopathy.
Rebeck GW; Cho HS; Grabowski TJ; Greenberg SM
Amyloid; 2001 Jul; 8 Suppl 1():43-7. PubMed ID: 11676289
[TBL] [Abstract][Full Text] [Related]
59. Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease.
Murakami K; Irie K; Morimoto A; Ohigashi H; Shindo M; Nagao M; Shimizu T; Shirasawa T
J Biol Chem; 2003 Nov; 278(46):46179-87. PubMed ID: 12944403
[TBL] [Abstract][Full Text] [Related]
60. Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study.
Quiroz YT; Schultz AP; Chen K; Protas HD; Brickhouse M; Fleisher AS; Langbaum JB; Thiyyagura P; Fagan AM; Shah AR; Muniz M; Arboleda-Velasquez JF; Munoz C; Garcia G; Acosta-Baena N; Giraldo M; Tirado V; Ramírez DL; Tariot PN; Dickerson BC; Sperling RA; Lopera F; Reiman EM
JAMA Neurol; 2015 Aug; 72(8):912-9. PubMed ID: 26121081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
